Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
30% supramolecular salicylic acid for papulopustular rosacea
ChiCTR2000029833Phase 4Recruiting
- Sponsor
- Second Affiliated Hospital of Fujian Medical University
- Start
- Oct 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of Salvax and metronidazole in rosacea (2 arms), sponsored by Second Affiliated Hospital of Fujian Medical University. Primary endpoints: erythema index, skin hydration value and 6 more. Started Oct 2017; status: recruiting.
02
Drugs
Salvaxmetronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on ChiCTR2000029833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000029833.